208 E7777 (denileukin diftitox) enhances anti-tumor activity and significantly extends survival benefit of anti-PD-1 in syngeneic solid tumor models - Mary Woodall-Jappe; A Raghav Chari; Anil Namboodiripad; Chandrasekhar Goda (Journal for ImmunoTherapy of Cancer, 2020)